Works matching DE "PEMETREXED"

Results: 777

Malignant Sarcomatoid Pleural Mesothelioma Presenting as a Chest Wall Tumor.

Published in:

Indian Journal of Surgery, 2023, v. 85, p. 548, doi. 10.1007/s12262-022-03555-5

By:

Reddy, Chemuru Munisekhar;
Reddy, H. V. Rajashekara

Publication type:

Article

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malign Peritoneal Mesothelioma: Clinical Aspects and Therapeutic Perspectives.

Published in:

Indian Journal of Surgery, 2022, v. 84, n. 1, p. 21, doi. 10.1007/s12262-021-02809-y

By:

Sezer, Taylan Özgür;
Miftari, Almir;
Fırat, Özgür;
Ersin, Sinan

Publication type:

Article

Bimodal Therapeutic Agents Against Glioblastoma, One of the Most Lethal Forms of Cancer.

Published in:

Chemistry - A European Journal, 2020, v. 26, n. 63, p. 14335, doi. 10.1002/chem.202002963

By:

Couto, Marcos;
Alamón, Catalina;
Nievas, Susana;
Perona, Marina;
Dagrosa, María Alejandra;
Teixidor, Francesc;
Cabral, Pablo;
Viñas, Clara;
Cerecetto, Hugo

Publication type:

Article

Predominance of MGMT promoter methylation among Pakistani glioblastoma patients.

Published in:

Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-024-09363-2

By:

Muhammad, Noor;
Fasih, Samir;
Malik, Bilal;
Hameed, Shahid;
Loya, Asif;
Rashid, Muhammad Usman

Publication type:

Article

MiR-320a upregulation contributes to the effectiveness of pemetrexed by inhibiting the growth and invasion of human lung cancer cell line (Calu-6).

Published in:

Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-024-09207-z

By:

Ghorbani Alvanegh, Akbar;
Arpanaei, Ayyoob;
Esmaeili Gouvarchin Ghaleh, Hadi;
Mohammad Ganji, Shahla

Publication type:

Article

Predictive factors associated with pemetrexed acute toxicity.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 5, p. 635, doi. 10.1007/s00228-023-03478-4

By:

Bonnet, Mathilde;
Jouinot, Anne;
Boudou-Rouquette, Pascaline;
Seif, Vanessa;
Villeminey, Clémentine;
Arrondeau, Jennifer;
Vidal, Michel;
Batista, Rui;
Wislez, Marie;
Blanchet, Benoit;
Goldwasser, François;
Thomas-Schoemann, Audrey

Publication type:

Article

Better survival in impaired renal function patients with metastatic non-small cell lung cancer treated by cisplatin-pemetrexed.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 11, p. 1573, doi. 10.1007/s00228-020-02935-8

By:

Magali, Louis;
Pascal, Foucher;
Serge, Aho;
Mathieu, Boulin;
Ayoube, Zouak;
Claire, Tinel;
Christiane, Mousson

Publication type:

Article

FDA Approves Amivantamab-Vmjw for EGFR Exon 20 Insertion--Variant NSCLC.

Published in:: ONS Voice, 2024, p. 1
Publication type:: Article

Efficacy of consolidation of immune checkpoint inhibitor after chemoradiation for unresectable, locally advanced PD‑L1 negative non‑small cell lung cancer: A systematic review and meta‑analysis.

Published in:

Oncology Letters, 2024, v. 27, n. 6, p. N.PAG, doi. 10.3892/ol.2024.14375

By:

Rao, Sunyin;
Min, Li;
Zhao, Jie;
Su, Juan;
Ye, Lianhua

Publication type:

Article

Psoriasis induced by first‑line pembrolizumab in metastatic non‑small cell lung cancer: A case report.

Published in:

2023

By:

Gatti, Federica;
Caruso, Gianluca;
Potenza, Concetta;
Santini, Daniele;
Petrozza, Vincenzo;
Annetta, Alessandro;
Ceddia, Serena;
Cosimati, Antonella;
Brandi, Martina;
Sorrentino, Veronica;
Proietti, Ilaria;
Rossi, Luigi

Publication type:

Case Study

Neoadjuvant immune checkpoint inhibitor treatment + chemotherapy (vs. chemotherapy alone) for locally advanced non‑small cell lung cancer: A retrospective cohort study.

Published in:

Oncology Letters, 2023, v. 26, n. 1, p. N.PAG, doi. 10.3892/ol.2023.13878

By:

Yang, Yi;
Liu, Zaoyang

Publication type:

Article

Antiaging gene Klotho regulates epithelial-mesenchymal transition and increases sensitivity to pemetrexed by inducing lipocalin-2 expression.

Published in:

Oncology Letters, 2021, v. 21, n. 5, p. N.PAG, doi. 10.3892/ol.2021.12679

By:

Takegahara, Kyoshiro;
Usuda, Jitsuo;
Inoue, Tatsuya;
Sonokawa, Takumi;
Matsui, Takuma;
Matsumoto, Mitsuo

Publication type:

Article

A three serum miRNA panel as diagnostic biomarkers of radiotherapy-related metastasis in non-small cell lung cancer.

Published in:

Oncology Letters, 2020, v. 20, n. 5, p. 1, doi. 10.3892/ol.2020.12099

By:

JIN LV;
JUAN AN;
YANG-DONG ZHANG;
ZHAO-XIA LI;
GUANG-LI ZHAO;
JUN GAO;
WEN-WEI HU;
HUO-MING CHEN;
AI-MIN LI;
QI-SHENG JIANG

Publication type:

Article

PLAC8 inhibits oral squamous cell carcinogenesis and epithelial-mesenchymal transition via the Wnt/β-catenin and PI3K/Akt/GSK3β signaling pathways.

Published in:

Oncology Letters, 2020, v. 20, n. 5, p. 1, doi. 10.3892/ol.2020.11989

By:

JUNLU WU;
XUETAO WANG;
ANQUAN SHANG;
VELLA, GIOVANNA;
ZUJUN SUN;
PING JI;
DIANYU YANG;
AIMING WAN;
YIWEN YAO;
DONG LI

Publication type:

Article

Inhibition of miR-18a-3p reduces proliferation of mesothelioma cells and sensitizes them to cisplatin.

Published in:

Oncology Letters, 2020, v. 19, n. 6, p. 4161, doi. 10.3892/ol.2020.11504

By:

RUI SUZUK;
AMATYA, VISHWA JEET;
KEI KUSHITANI;
YUICHIRO KAI;
TAKAHIRO KAMBARA;
YUTARO FUJII;
YUKIO TAKESHIMA

Publication type:

Article

Clinical efficacy and safety evaluation of pemetrexed combined with radiotherapy in treatment of patients with lung adenocarcinoma brain metastasis.

Published in:

Oncology Letters, 2019, v. 17, n. 3, p. 2874

By:

Zhang, Guoqiao;
Zeng, Rong;
Wang, Kai;
A, Yinzhuoyang;
Li, Linhai;
Gong, Kunmei

Publication type:

Article

Pemetrexed exerts anticancer effects by inducing G<sub>0</sub>/G<sub>1</sub>-phase cell cycle arrest and activating the NOXA/Mcl-1 axis in human esophageal squamous cell carcinoma cells.

Published in:

Oncology Letters, 2019, v. 17, n. 2, p. 1851

By:

Li, Xinying;
Song, Hongxia;
Kong, Feng;
Guo, Yanxia;
Chen, Yuan;
Zhang, Lu;
Gao, Dongfang;
Zhao, Xiaofei;
Zhang, Han

Publication type:

Article

Thymidylate synthase predicts poor response to pemetrexed chemotherapy in patients with advanced breast cancer.

Published in:

Oncology Letters, 2018, v. 16, n. 3, p. 3274, doi. 10.3892/ol.2018.8973

By:

Shan, Fei;
Liu, Yu-Lin;
Wang, Qiang;
Shi, Yan-Long

Publication type:

Article

Evaluation of plasma microRNA levels to predict insensitivity of patients with advanced lung adenocarcinomas to pemetrexed and platinum.

Published in:

Oncology Letters, 2016, v. 12, n. 6, p. 4829, doi. 10.3892/ol.2016.5295

By:

JINGHUA ZHU;
YUHUA QI;
JIANZHONG WU;
MEIQI SHI;
JIFENG FENG;
LONGBANG CHEN

Publication type:

Article

Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases.

Published in:

Oncology Letters, 2016, v. 12, n. 6, p. 4635, doi. 10.3892/ol.2016.5268

By:

STEFANOU, DIMITRA;
STAMATOPOULOU, SOFIA;
SAKELLAROPOULOU, ANTIGONI;
AKAKIOS, GAVRIIL;
GKIAOURAKI, MARINA;
GKEKA, DESPINA;
PREVEZANOU, MARIA;
ARDAVANIS, ALEXANDROS

Publication type:

Article

Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer.

Published in:

Oncology Letters, 2014, v. 8, n. 6, p. 2453, doi. 10.3892/ol.2014.2552

By:

TAKASHI YOKOI;
YOSHITARO TORII;
YUICHI KATASHIBA;
HIROYUKI SUGIMOTO;
TSUTOMU TANIJIRI;
MAKOTO OGATA;
NORIKO INAGAKI;
KAYOKO KIBATA;
MINA HAYASHI;
MAIKO NIKI;
TOSHIKI SHIMIZU;
TAKAYUKI MIYARA;
TAKAYASU KURATA;
SHOSAKU NOMURA

Publication type:

Article

Comparison of pemetrexed plus cisplatin with gemcitabine plus docetaxel in refractory/metastatic osteosarcoma: Clinical outcomes from a retrospective database monitored in a single institute.

Published in:

Oncology Letters, 2014, v. 8, n. 5, p. 2243, doi. 10.3892/ol.2014.2472

By:

WEN-XI YU;
LI-NA TANG;
FENG LIN;
YANG YAO;
ZAN SHEN

Publication type:

Article

Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapy.

Published in:

Oncology Letters, 2014, v. 7, n. 6, p. 2073, doi. 10.3892/ol.2014.1988

By:

WENJUN MOU;
HUI XUE;
HONGLI TONG;
SHENGJIE SUN;
ZHUHONG ZHANG;
CHUNYAN ZHANG;
QIYU SUN;
JING DONG;
XINYU WEN;
GUANGTAO YAN;
YAPING TIAN

Publication type:

Article

Significance of thymidylate synthase expression for resistance to pemetrexed in pulmonary adenocarcinoma.

Published in:

Oncology Letters, 2014, v. 7, n. 1, p. 227, doi. 10.3892/ol.2013.1688

By:

MIN YANG;
WEI-FEI FAN;
XIAO-LIN PU;
FU-YIN LIU;
LI-JUAN MENG;
JUN WANG

Publication type:

Article

Favorable response to pemetrexed, cisplatin and bevacizumab in invasive mucinous adenocarcinoma: A case report and literature review.

Published in:

Molecular & Clinical Oncology, 2018, v. 9, n. 2, p. 192, doi. 10.3892/mco.2018.1651

By:

Sun, Xian Wen;
Ding, Yong Jie;
Zhang, Yu Yan;
Chen, Pei Li;
Yan, Ya Ru;
Shen, Ji Min;
Li, Qing Yun

Publication type:

Article

Doublet chemotherapy with cisplatin and pemetrexed is associated with a favorable outcome in patients with advanced non-squamous non-small-cell lung cancer who are eligible for bevacizumab and maintenance therapy.

Published in:

Molecular & Clinical Oncology, 2016, v. 5, n. 5, p. 575, doi. 10.3892/mco.2016.1001

By:

KAZUHISA NAKASHIMA;
HARUYASU MURAKAMI;
SHOTA OMORI;
KAZUSHIGE WAKUDA;
AKIRA ONO;
HIROTSUGU KENMOTSU;
TATEAKI NAITO;
MASAHIRO ENDO;
TOSHIAKI TAKAHASHI

Publication type:

Article

Effect of liver toxicity on clinical outcome of patients with non-small-cell lung cancer treated with pemetrexed.

Published in:

Molecular & Clinical Oncology, 2015, v. 3, n. 2, p. 334, doi. 10.3892/mco.2014.452

By:

YUICHI SAKAMORI;
YOUNG HAK KIM;
HIRONORI YOSHIDA;
TAKASHI NAKAOKU;
HIROKI NAGAI;
YOSHITAKA YAGI;
HIROAKI OZASA;
MICHIAKI MISHIMA

Publication type:

Article

Efficacy and Toxicity of Maintenance Pemetrexed Following Induction Treatment with Pemetrexed Plus Cisplatin for Advanced Non-small-cell Non-squamous Carcinoma of the Lung.

Published in:

Forum of Clinical Oncology, 2015, v. 6, n. 2, p. 14, doi. 10.1515/fco-2015-0008

By:

Jegannathen, A.;
Giridharan, S.;
Kim, D. H.;
Gilani, S.;
Kinmond, A.

Publication type:

Article

Impact of Different Treatment Regimens and Timeframes in the Plasmatic Metabolic Profiling of Patients with Lung Adenocarcinoma.

Published in:

Metabolites (2218-1989), 2023, v. 13, n. 12, p. 1180, doi. 10.3390/metabo13121180

By:

Madama, Daniela;
Carrageta, David F.;
Guerra-Carvalho, Bárbara;
Botelho, Maria F.;
Oliveira, Pedro F.;
Cordeiro, Carlos R.;
Alves, Marco G.;
Abrantes, Ana M.

Publication type:

Article

Pemetrexed Hinders Translation Inhibition upon Low Glucose in Non-Small Cell Lung Cancer Cells.

Published in:

Metabolites (2218-1989), 2021, v. 11, n. 4, p. 198, doi. 10.3390/metabo11040198

By:

Piecyk, Marie;
Triki, Mouna;
Laval, Pierre-Alexandre;
Dragic, Helena;
Cussonneau, Laura;
Fauvre, Joelle;
Duret, Cédric;
Aznar, Nicolas;
Renno, Toufic;
Manié, Serge N.;
Chaveroux, Cédric;
Ferraro-Peyret, Carole

Publication type:

Article

Pemetrexed-induced lower limb pseudocellulitis.

Published in:

Clinical & Experimental Dermatology, 2017, v. 42, n. 8, p. 914, doi. 10.1111/ced.13202

By:

Liau, M. M.;
Santosa, A.;
Huang, J.;
Tan, L. C.

Publication type:

Article

Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients.

Published in:

Genes, 2024, v. 15, n. 6, p. 750, doi. 10.3390/genes15060750

By:

Senturk Kirmizitas, Tugce;
van den Berg, Caroline;
Boers, Ruben;
Helmijr, Jean;
Makrodimitris, Stavros;
Dag, Hamit Harun;
Kerkhofs, Marijn;
Beaufort, Corine;
Kraan, Jaco;
van IJcken, Wilfred F. J.;
Gribnau, Joost;
Garkhail, Pakriti;
Boer, Gatske Nieuwenhuyzen-de;
Roes, Eva-Maria;
van Beekhuizen, Heleen;
Gunel, Tuba;
Wilting, Saskia;
Martens, John;
Jansen, Maurice;
Boere, Ingrid

Publication type:

Article

Molecular Docking Study of Naturally Derived Flavonoids with Antiapoptotic BCL-2 and BCL-XL Proteins toward Ovarian Cancer Treatment.

Published in:

Journal of Pharmacy & Bioallied Sciences, 2020, v. 12, p. S676, doi. 10.4103/jpbs.JPBS_272_19

By:

Ghani, Mohd Faiz Abd;
Othman, Rozana;
Nordin, Noraziah

Publication type:

Article

A Novel Intergenic Region (chr2: 30,316,870)-ALK Fusion in a Patient with Lung Adenocarcinoma Responding to Crizotinib Combined with Pemetrexed Treatment: A Case Report.

Published in:

2024

By:

Zhou, Danfei;
Ying, Jun;
Hu, Shanshan;
Li, Jiangdong;
Liu, Haijian

Publication type:

Case Study

Efficacy and Safety of Gefitinib Plus Pemetrexed/Platinum in Advanced EGFR-Mutated Lung Adenocarcinoma Patients: A Real-World Observational Study [Retraction].

Published in:

2022

By:

Wang, Rui;
Wu, Qiang

Publication type:

Correction Notice

Efficacy and Safety of Gefitinib Plus Pemetrexed/Platinum in Advanced EGFR-Mutated Lung Adenocarcinoma Patients: A Real-World Observational Study.

Published in:

OncoTargets & Therapy, 2022, v. 15, p. 31, doi. 10.2147/OTT.S332998

By:

Wang, Rui;
Wu, Qiang

Publication type:

Article

Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways.

Published in:

OncoTargets & Therapy, 2020, v. 13, p. 12325, doi. 10.2147/OTT.S276125

By:

Zhen, Hongchao;
Li, Guangxin;
Zhao, Pengfei;
Zhang, Ying;
Wang, Jing;
Yu, Junxian;
Cao, Bangwei

Publication type:

Article

Advanced Squamous Cell Carcinoma of the Lung: Current Treatment Approaches and the Role of Afatinib.

Published in:

OncoTargets & Therapy, 2020, v. 13, p. 9305, doi. 10.2147/OTT.S250446

By:

Santos, Edgardo S;
Hart, Lowell

Publication type:

Article

MiR-4766-5p Inhibits The Development And Progression Of Gastric Cancer By Targeting NKAP.

Published in:

OncoTargets & Therapy, 2019, v. 12, p. 8525, doi. 10.2147/OTT.S220234

By:

Wei, Yaning;
Wang, Yanan;
Zang, Aimin;
Wang, Zhiyu;
Fang, Guotao;
Hong, Dan

Publication type:

Article

A pooled meta-analysis of PD-1/L1 inhibitors incorporation therapy for advanced non-small cell lung cancer.

Published in:

OncoTargets & Therapy, 2019, v. 12, p. 4955, doi. 10.2147/OTT.S200615

By:

Wan, Ning;
Ji, Bo;
Li, Jian;
Jiang, Jie;
Yang, Chen;
Zhang, Tiantian;
Huang, Wenjie

Publication type:

Article

Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial.

Published in:

OncoTargets & Therapy, 2018, v. 11, p. 8575, doi. 10.2147/OTT.S160358

By:

Wu, Yi-Long;
Xu, Chong-Rui;
Hu, Cheng-Ping;
Feng, Jifeng;
Lu, Shun;
Huang, Yunchao;
Li, Wei;
Hou, Mei;
Shi, Jian Hua;
Märten, Angela;
Fan, Jean;
Peil, Barbara;
Zhou, Caicun

Publication type:

Article

Perioperative chemotherapy with pemetrexed and cisplatin for pulmonary large-cell neuroendocrine carcinoma: a case report and literature review.

Published in:

2018

By:

Tang, Hong;
Wang, Hongyan;
Xi, Shaoyan;
He, Chunyu;
Chang, Yuxi;
Wang, Qiming;
Wu, Yufeng

Publication type:

Case Study

Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction.

Published in:

OncoTargets & Therapy, 2017, v. 10, p. 3211, doi. 10.2147/OTT.S136837

By:

Takaya Ikeda;
Hiroyuki Yamaguchi;
Katsumi Nakatomi;
Hiroshi Mukae;
Midori Shimada;
Masaaki Fukuda;
Takeshi Kitazaki;
Kohji Hashiguchi;
Minoru Fukuda;
Kazuto Ashizawa

Publication type:

Article

Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study.

Published in:

OncoTargets & Therapy, 2017, v. 10, p. 2595, doi. 10.2147/OTT.S134684

By:

Yi Sun;
Yong Wang;
Shaolong Han;
Bo Xing;
Hong Li;
Yufang Zhu;
Shizhen Zhou;
Xiuhua Wang;
Jun Xu;
Rongjie Tao

Publication type:

Article

Comparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-center experience.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 6305, doi. 10.2147/OTT.S113374

By:

Liping Lin;
Juanjuan Zhao;
Jiazhu Hu;
Fuxi Huang;
Jianjun Han;
Yan He;
Xiaolong Cao

Publication type:

Article

Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 5287, doi. 10.2147/OTT.S105976

By:

Yoshiro Nakahara;
Yusuke Takagi;
Yukio Hosomi;
Akiko Kagei;
Tomohiro Yamamoto;
Takeshi Sawada;
Makiko Yomota;
Yusuke Okuma;
Shinichiro Mikura;
Tatsuru Okamura

Publication type:

Article

Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review.

Published in:

2016

By:

Haiyong Wang;
Hui Zhu;
Li Kong;
Jinming Yu

Publication type:

Case Study

Efficacy of pemetrexed-based regimen in relapsed advanced thymic epithelial tumors and its association with thymidylate synthetase level.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 4527, doi. 10.2147/OTT.S105949

By:

Xinyu Qian;
Zhengbo Song

Publication type:

Article

Critical appraisal of pemetrexed in the treatment of NSCLC and metastatic pulmonary nodules.

Published in:

OncoTargets & Therapy, 2014, v. 7, p. 937, doi. 10.2147/OTT.S45148

By:

Xin Li;
Sen Wei;
Jun Chen

Publication type:

Article

Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma.

Published in:

OncoTargets & Therapy, 2014, v. 7, p. 799, doi. 10.2147/OTT.S62639

By:

Jeng-Sen Tseng;
Tsung-Ying Yang;
Kun-Chieh Chen;
Kuo-Hsuan Hsu;
Chong-Jen Yu;
Wei-Yu Liao;
Chi-Ren Tsai;
Meen-Hsin Tsai;
Sung-Liang Yu;
Kang-Yi Su;
Chen, Jeremy J. W.;
Hsuan-Yu Chen;
Gee-Chen Chang

Publication type:

Article